We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · July 20, 2020

Conbercept Versus Ranibizumab for Retinopathy of Prematurity

Acta Ophthalmologica


Additional Info

Acta Ophthalmologica
Comparison of the Effectiveness of Conbercept and Ranibizumab Treatment for Retinopathy of Prematurity
Acta Ophthalmol 2020 May 08;[EPub Ahead of Print], Y Cheng, X Zhu, D Linghu, J Liang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading